Role of disease risk scores in comparative effectiveness research with emerging therapies
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Role of disease risk scores in comparative effectiveness research with emerging therapies
Authors
Keywords
-
Journal
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
Volume 21, Issue -, Pages 138-147
Publisher
Wiley
Online
2012-05-03
DOI
10.1002/pds.3231
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Performance of Disease Risk Scores, Propensity Scores, and Traditional Multivariable Outcome Regression in the Presence of Multiple Confounders
- (2011) P. G. Arbogast et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- Effects of Adjusting for Instrumental Variables on Bias and Precision of Effect Estimates
- (2011) Jessica A. Myers et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- Invited Commentary: Understanding Bias Amplification
- (2011) J. Pearl AMERICAN JOURNAL OF EPIDEMIOLOGY
- Clinical Referral Patterns for Carotid Artery Stenting Versus Carotid Endarterectomy
- (2011) Ryan B. Longmore et al. Circulation-Cardiovascular Interventions
- Assessing the Comparative Effectiveness of Newly Marketed Medications: Methodological Challenges and Implications for Drug Development
- (2011) S Schneeweiss et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- A combined comorbidity score predicted mortality in elderly patients better than existing scores
- (2011) Joshua J. Gagne et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- Benefit/Risk Assessment for Breast Cancer Chemoprevention With Raloxifene or Tamoxifen for Women Age 50 Years or Older
- (2011) Andrew N. Freedman et al. JOURNAL OF CLINICAL ONCOLOGY
- Treatment Effects in the Presence of Unmeasured Confounding: Dealing With Observations in the Tails of the Propensity Score Distribution--A Simulation Study
- (2010) T. Sturmer et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- Rosuvastatin for Primary Prevention Among Individuals With Elevated High-Sensitivity C-Reactive Protein and 5% to 10% and 10% to 20% 10-Year Risk
- (2010) Paul M Ridker et al.
- A basic study design for expedited safety signal evaluation based on electronic healthcare data
- (2010) Sebastian Schneeweiss PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Adjustment for Multiple Cardiovascular Risk Factors Using a Summary Risk Score
- (2009) Patrick G. Arbogast et al. EPIDEMIOLOGY
- High-dimensional Propensity Score Adjustment in Studies of Treatment Effects Using Health Care Claims Data
- (2009) Sebastian Schneeweiss et al. EPIDEMIOLOGY
- Confounder summary scores when comparing the effects of multiple drug exposures
- (2009) Suzanne M. Cadarette et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- The prognostic analogue of the propensity score
- (2008) B. B. Hansen BIOMETRIKA
- Improvements in Long-Term Mortality After Myocardial Infarction and Increased Use of Cardiovascular Drugs After Discharge
- (2008) Soko Setoguchi et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now